Japan Breast Cancer Diagnostics And Therapeutics Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2025

Japan breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 10.2% during the forecast period. The major factors that are driving the market include the prevalence of breast cancer, awareness programs by government and private organizations and government funding for research. According to the National cancer centre, breast cancer is the most common cancer in women, about 89,100 cases are estimated in 2017. Breast cancer is the 5th largest cause of mortality in Japan, it was estimated at about 14,400 in 2017. The increasing incidences enable the growth of the screening rates thus also grow the market in the country. The 'Pink Ribbon Festival' initiated by the Japan Cancer Society that enables to raise of public awareness of the importance of early diagnosis and treatment of breast cancer that further contribute to the growth of the market.

To Request a Sample of our Report on Japan Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/japan-breast-cancer-diagnostics-therapeutics-market

Japan breast cancer diagnostics and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others.

(Get 15% Discount on Buying this Report)

A full Report of Japan Breast Cancer Diagnostics And Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/japan-breast-cancer-diagnostics-therapeutics-market

Japan Breast Cancer Diagnostics And Therapeutics Market Segmentation

By Cancer Type

· Ductal Carcinoma In-Situ (DCIS)

· Invasive Ductal Carcinoma (IDC)

· Triple Negative Breast Cancer (TNBC)

· Inflammatory Breast Cancer

· Others (Invasive lobular carcinoma)

By Diagnostics

· Mammography

· Biopsy

· PET/CET

· Ultrasound

· Others (MRI)

By Therapeutics

· Chemotherapy

· Hormone Therapy

· Targeted Therapy

· Others (Radiation Therapy, Surgery)

Company Profiles

· AstraZeneca PLC

· Bayer AG

· GlaxoSmithKline PLC

· Johnson & Johnson Services, Inc.

· Merck & Co., Inc.

· Novartis International AG

· F. Hoffmann-La Roche AG

· Sanofi S.A.

· Siemens Healthcare GmbH

· Sun Pharmaceutical Industries Ltd.

· Pfizer Inc.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.